Seroprevalence of SARS-CoV-2–Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence in cancer patients may vary widely dependent on the geographic area and this has significant implications for oncological care. The aim of this observational, prospective study was to assess the seroprevalence of SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Cantini, Luca, Bastianelli, Lucia, Lupi, Alessio, Pinterpe, Giada, Pecci, Federica, Belletti, Giovanni, Stoico, Rosa, Vitarelli, Francesca, Moretti, Marco, Onori, Nicoletta, Giampieri, Riccardo, Rocchi, Marco Bruno Luigi, Berardi, Rossana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038489/
https://www.ncbi.nlm.nih.gov/pubmed/33916569
http://dx.doi.org/10.3390/jcm10071503